ICD10 Disease Category |
Disease Name |
ICD10 Code |
Linked Targets |
E00-E89: Endocrine, nutritional and metabolic diseases |
Metabolic disorders |
E70-E89 |
HTR2C |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders |
Generalized anxiety disorder |
F32, F40-F42, F41.1 |
HTR2C |
W85-W99: Exposure to electric current, radiation and extreme ambient air temperature and pressure |
Diagnostic test to differentiate primary and secondary hypothyroidism |
W88 |
TSHR |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders |
Drug abuse |
F10-F19 |
HTR2C |
R00-R99: Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified |
Acute or chronic pain |
R52, G89 |
TRPV1 |
G00-G99: Diseases of the nervous system G00-G99 |
Acute migraine |
G43 |
TRPV1 |
C00-D49: Neoplasms |
Acute myeloid leukemia |
C92.0 |
TP53; TP53 |
E00-E89: Endocrine, nutritional and metabolic diseases |
Diabetic neuropathy |
E11.40 |
TRPV1 |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders |
Major depressive disorder |
F32, F33, M32 |
MAOB; HTR2C; HTR2C |
C00-D49: Neoplasms |
Late-stage solid tumors |
C00-C75, C7A, C7B, D10-D36, D3A |
TP53 |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders |
Dementia |
F01-F07 |
MAOB |
C00-D49: Neoplasms |
Oral cavity cancer |
C00-C08 |
TP53 |
G00-G99: Diseases of the nervous system G00-G99 |
Neurodegenerative disease |
G30-G32 |
MAPT; MAOB |
C00-D49: Neoplasms |
Hematological malignancies |
C81-C86 |
TP53 |
C00-D49: Neoplasms |
Overactive bladder disorder |
C67, N32.81 |
TRPV1; TRPV1 |
R00-R99: Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified |
Chronic pathological pain |
R52, G89 |
TRPV1 |
G00-G99: Diseases of the nervous system G00-G99 |
Alzheimer disease |
G30 |
MAPT; MAOB |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders |
Idiopathic parkinson's disease |
F02.3, G20 |
MAOB |
G00-G99: Diseases of the nervous system G00-G99 |
Parkinson's disease |
G20 |
MAOB; MAOB |
G00-G99: Diseases of the nervous system G00-G99 |
Pain |
G64, G90.0, R52, G89 |
HTR2C; TRPV1; TRPV1 |
G00-G99: Diseases of the nervous system G00-G99 |
Migraine headaches |
G43 |
HTR2C |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders |
Alcohol use disorders |
F10.2 |
HTR2C |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders |
Psychotic disorders |
F20-F29 |
HTR2C |
C00-D49: Neoplasms |
Aggressive non-hodgkin's lymphoma |
C81, C81-C86, C82-C85, C91-C95 |
HTR2C |
NA: NA |
Primary insomnia |
NA |
HTR2C |
S00-T88: Injury, poisoning and certain other consequences of external causes |
Toxicity |
T36-T50, T51-T65 |
TP53 |
C00-D49: Neoplasms |
Thyroid cancer diagnosis |
C73 |
TSHR |
I00-I99: Diseases of the circulatory system |
Neurological disease |
I21, I22, R52, R52.1-R52.2, R60.9, G89 |
HTR2C |
G00-G99: Diseases of the nervous system G00-G99 |
Neuropathic pain |
G64, G90.0 |
TRPV1 |
N00-N99: Diseases of the genitourinary system |
Urinary incontinence |
N39.3, N39.4, R32 |
TRPV1 |
E00-E89: Endocrine, nutritional and metabolic diseases |
Obesity |
E66 |
MAOB; HTR2C; HTR2C |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders |
Schizophrenia |
F20 |
HTR2C |
NA: NA |
Esophagus sensitivity |
NA |
TRPV1 |
C00-D49: Neoplasms |
Cancer |
C00-C96 |
TP53 |
A00-B99: Certain infectious and parasitic diseases |
Fungal infections |
B35-B49 |
RAB9A |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders |
Major depressive episode without melancholia |
F30-F39 |
MAOB |
C00-D49: Neoplasms |
Solid tumours |
C00-D48 |
TP53 |
NA: NA |
Sleep initiation and maintenance disorders |
NA |
HTR2C |
G00-G99: Diseases of the nervous system G00-G99 |
Central nervous system disease |
G00-G99 |
MAPT; MAOB |
L00-L99: Diseases of the skin and subcutaneous tissue |
Atopic dermatitis |
L00-L99 |
TRPV1 |
A00-B99: Certain infectious and parasitic diseases |
Bacterial infections |
A00-B99 |
MAOB |
J00-J99: Diseases of the respiratory system |
Asthma |
J45 |
TRPV1 |
I00-I99: Diseases of the circulatory system |
Renal artery disease |
I70.1 |
TP53 |
C00-D49: Neoplasms |
Thyroid cancer |
C73 |
TSHR |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders |
Cognitive disorders |
F01-F07, F04, F05, R41.3 |
MAPT; MAOB |
R00-R99: Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified |
Musculoskeletal pain |
R52, G89 |
TRPV1 |
NA: NA |
Motor symptoms |
NA |
MAOB |
I00-I99: Diseases of the circulatory system |
Moderate to severe hypertension |
I10-I16 |
MAOB |
K00-K95: Diseases of the digestive system |
Gastroesophageal reflux disease |
K21 |
TRPV1 |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders |
Mood disorder |
F30-F39 |
HTR2C |
E00-E89: Endocrine, nutritional and metabolic diseases |
Diabetes |
E23.2, N25.1 |
HTR2C |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders |
Depression |
F30-F39 |
MAOB; HTR2C |
C00-D49: Neoplasms |
Colorectal cancer |
C18-C21 |
TP53 |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders |
Anxiety disorder |
F32, F40-F42 |
MAOB; CYP3A4; HTR2C |
A00-B99: Certain infectious and parasitic diseases |
Postherpetic neuralgia |
B02.2, G44.847, G53.0 |
TRPV1 |
C00-D49: Neoplasms |
Head and neck cancer |
C07-C14, C32-C33 |
TP53 |
H60-H95: Diseases of the ear and mastoid process |
Hearing disorder |
H90.5 |
TP53 |
R00-R99: Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified |
Cough |
R05 |
TRPV1 |